Max Nisen, Bloomberg

Max Nisen


New York, NY, United States

Contact Max

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

  • Unknown
  • Bloomberg
  • Washington Post
  • BQ Prime
  • The Chainsaw
  • Quartz
  • Business Insider
  • Slate

Past articles by Max:

American Travel Rules Discriminate Against Europeans

Entry to the U.S. requires more proof of vaccination than should be necessary, while unvaccinated people are free to fly anywhere within the country. → Read More

By Allowing Vaccine Mixing, the FDA Simplifies the Booster Rollout

In a shift toward much-needed flexibility, drug regulators will enable all Americans seeking greater protection against Covid-19 to easily get it. → Read More

Colin Powell’s Death Argues for Vaccines, Not Against Them

The former military officer and statesman needed as many people around him as possible to be vaccinated to diminish his chances of encountering the virus. → Read More

Who Will Take Merck’s New Covid-19 Pills?

The antivirals may be approved before year’s end. But healthy people under 65 may not get them. → Read More

Merck’s New Antiviral Promises to Make Covid Less Deadly

It should also be relatively easy to scale up manufacturing and get pills out to the people who need them worldwide. → Read More

Crispr Is Still Promising, Even If Editas’s Experiment Falls Short

One attempt to repair a faulty eye gene had disappointing results, but the technology can be expected to one day treat all sorts of genetic diseases. → Read More

Unproven Covid Pills Could Be Biden’s Secret Weapon

Highly convenient oral drugs could be a pandemic game changer. With enough investment, the U.S. could make a whole lot of them for the world. → Read More

Liars May Get Covid Boosters Before Those in Need

U.S. experts had a difficult series of decisions to make about boosters based on limited data. But it’s hard to say their final advice is clear, evidence-based or in the best interests of public health. → Read More

12 of Today’s Most Pressing Covid Questions Answered

From the need for boosters to kids and Covid and the risk of new variants, here’s what you need to know. → Read More

Biden's Rushed Booster Plan Is Already Getting Messy

Setting a timeline before experts weighed in put improper pressure on scientific agencies, raised expectations and now risks creating confusion when the focus should be on first shots. → Read More

Can Delta Air Lines Make Unvaccinated Workers Pay Up?

The airline is the first major corporation to say it will slap a big health-insurance surcharge on workers who haven’t had their Covid-19 shots. Is this a good idea? → Read More

The Tesla-fication of Moderna Is a Rich Tale

What could possibly unite a drug developer with a manufacturer of electric cars? It’s all in the narrative. → Read More

A More Infectious Covid Needs a Quicker Test

The rise of the delta variant makes testing more important than ever, even among the vaccinated. Rapid antigen tests are the right tool for the job. → Read More

How Scary Is the Summer Sunscreen Scare?

Recent reports about possible carcinogens in certain sunscreens have raised safety concerns, but don't overreact. Here’s what you need to know. → Read More

New York's Vaccine Mandate Should Be the Norm

Requiring proof of inoculation for certain indoor events offers the best chance of increasing vaccine uptake and stopping the spread of the virus. → Read More

Three Reasons the New CDC Mask Guidance Makes Sense

Covid vaccines are highly effective. But the rapid spread of the delta variant changes the equation. → Read More

London’s Delta Surge Should Jolt New York

Heavily vaccinated London is seeing thousands of cases a day and an uptick in hospitalizations. New York may be in store for the same – or worse. → Read More

Weight-Loss Drug Could Help Millions. Will They Get It?

The U.S. health system focuses on acute care and short-term costs at the expense of preventative treatment. → Read More

UnitedHealth’s Results Flag Trouble Spots for Rivals

A growing surge of previously delayed care could turn medical costs into a larger-than-expected negative for insurers. → Read More

Medicare Needs to Cover Dental, Hearing and Vision Care

In the half-century since the program began, these services have grown too expensive for seniors to afford. → Read More